Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...
Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.
announced that it had plans to sell their now-bankrupt company to Optum, a division of the UnitedHealth Group. The deal would involve Optum acquiring all issued and outstanding capital stock of ...